APO Research
Talk to an analyst

APO RESEARCH · REPORT

Long-acting Insulin Injection

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Long-acting Insulin Injection Market Analysis and Forecast 2026-2032

23 December 2025204 pages

Choose your research edition.

Industry ResearchLong-acting Insulin Injection Industry Research Report 2026139 pages · $2,950 USDIndustry Growth & TrendsGlobal Long-acting Insulin Injection Industry Growth and Trends Forecast to 2032118 pages · $3,450 USDMarket StructureGlobal Long-acting Insulin Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Long-acting Insulin Injection Market Outlook and Growth Opportunities 2026208 pages · $4,250 USDMarket Analysis & ForecastGlobal Long-acting Insulin Injection Market Analysis and Forecast 2026-2032204 pages · $4,950 USD

Market perspective

The global Long-acting Insulin Injection market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Long-acting Insulin Injection is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Long-acting Insulin Injection is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Long-acting Insulin Injection is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Long-acting Insulin Injection is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Long-acting Insulin Injection include United Laboratories, Tonghua Dongbao, Sanofi, Novo Nordisk, Eli Lilly & Co, Gan & Lee, Wockhardt, Viatris and Swixx Biopharma, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Long-acting Insulin Injection, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Long-acting Insulin Injection, also provides the sales of main regions and countries. Of the upcoming market potential for Long-acting Insulin Injection, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Long-acting Insulin Injection sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Long-acting Insulin Injection market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Long-acting Insulin Injection sales, projected growth trends, production technology, application and end-user industry.

Long-acting Insulin Injection Segment by Company

United Laboratories

Tonghua Dongbao

Sanofi

Novo Nordisk

Eli Lilly & Co

Gan & Lee

Wockhardt

Viatris

Swixx Biopharma

Lupin Laboratories

KALBE PHARMA

INFION PHARMA

Cipla

Biocon Biologics

Biocare

Abbott Laboratories

Long-acting Insulin Injection Segment by Type

Insulin Glargine

Insulin Detemir

Insulin Degludec

Long-acting Insulin Injection Segment by Application

Type 1 Diabetes

Type 2 Diabetes

Long-acting Insulin Injection Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Long-acting Insulin Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Long-acting Insulin Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Long-acting Insulin Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Long-acting Insulin Injection in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Long-acting Insulin Injection manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Long-acting Insulin Injection sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Long-acting Insulin Injection Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Insulin Glargine Major Manufacturers Table 3. Insulin Detemir Major Manufacturers Table 4. Insulin Degludec Major Manufacturers Table 5. Global Long-acting Insulin Injection Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Type 1 Diabetes Major Manufacturers Table 7. Type 2 Diabetes Major Manufacturers Table 8. Long-acting Insulin Injection Industry Trends Table 9. Long-acting Insulin Injection Industry Drivers Table 10. Long-acting Insulin Injection Industry Opportunities and Challenges Table 11. Long-acting Insulin Injection Industry Restraints Table 12. Global Long-acting Insulin Injection Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 13. Global Long-acting Insulin Injection Revenue by Region (2021-2026) & (US$ Million) Table 14. Global Long-acting Insulin Injection Revenue by Region (2027-2032) & (US$ Million) Table 15. Global Long-acting Insulin Injection Revenue Market Share by Region (2021-2026) Table 16. Global Long-acting Insulin Injection Revenue Market Share by Region (2027-2032) Table 17. Global Long-acting Insulin Injection Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (k units) Table 18. Global Long-acting Insulin Injection Sales by Region (2021-2026) & (k units) Table 19. Global Long-acting Insulin Injection Sales by Region (2027-2032) & (k units) Table 20. Global Long-acting Insulin Injection Sales Market Share by Region (2021-2026) Table 21. Global Long-acting Insulin Injection Sales Market Share by Region (2027-2032) Table 22. Global Long-acting Insulin Injection Revenue by Manufacturers (US$ Million) & (2021-2026) Table 23. Global Long-acting Insulin Injection Revenue Market Share by Manufacturers (2021-2026) Table 24. Global Long-acting Insulin Injection Sales by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Long-acting Insulin Injection Sales Market Share by Manufacturers (2021-2026) Table 26. Global Long-acting Insulin Injection Sales Price (USD/unit) of Manufacturers (2021-2026) Table 27. Global Long-acting Insulin Injection Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 28. Global Long-acting Insulin Injection Key Manufacturers Manufacturing Sites & Headquarters Table 29. Global Long-acting Insulin Injection Manufacturers, Product Type & Application Table 30. Global Long-acting Insulin Injection Manufacturers' Establishment Date Table 31. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 32. Global Long-acting Insulin Injection by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 33. Global Long-acting Insulin Injection Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Long-acting Insulin Injection Revenue by Type (2021-2026) & (US$ Million) Table 35. Global Long-acting Insulin Injection Revenue by Type (2027-2032) & (US$ Million) Table 36. Global Long-acting Insulin Injection Revenue Market Share by Type (2021-2026) Table 37. Global Long-acting Insulin Injection Revenue Market Share by Type (2027-2032) Table 38. Global Long-acting Insulin Injection Sales by Type 2021 VS 2025 VS 2032 (k units) Table 39. Global Long-acting Insulin Injection Sales by Type (2021-2026) & (k units) Table 40. Global Long-acting Insulin Injection Sales by Type (2027-2032) & (k units) Table 41. Global Long-acting Insulin Injection Sales Market Share by Type (2021-2026) Table 42. Global Long-acting Insulin Injection Sales Market Share by Type (2027-2032) Table 43. Global Long-acting Insulin Injection Price by Type (2021-2026) & (USD/unit) Table 44. Global Long-acting Insulin Injection Price by Type (2027-2032) & (USD/unit) Table 45. Global Long-acting Insulin Injection Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 46. Global Long-acting Insulin Injection Revenue by Application (2021-2026) & (US$ Million) Table 47. Global Long-acting Insulin Injection Revenue by Application (2027-2032) & (US$ Million) Table 48. Global Long-acting Insulin Injection Revenue Market Share by Application (2021-2026) Table 49. Global Long-acting Insulin Injection Revenue Market Share by Application (2027-2032) Table 50. Global Long-acting Insulin Injection Sales by Application 2021 VS 2025 VS 2032 (k units) Table 51. Global Long-acting Insulin Injection Sales by Application (2021-2026) & (k units) Table 52. Global Long-acting Insulin Injection Sales by Application (2027-2032) & (k units) Table 53. Global Long-acting Insulin Injection Sales Market Share by Application (2021-2026) Table 54. Global Long-acting Insulin Injection Sales Market Share by Application (2027-2032) Table 55. Global Long-acting Insulin Injection Price by Application (2021-2026) & (USD/unit) Table 56. Global Long-acting Insulin Injection Price by Application (2027-2032) & (USD/unit) Table 57. United Laboratories Company Information Table 58. United Laboratories Business Overview Table 59. United Laboratories Long-acting Insulin Injection Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 60. United Laboratories Long-acting Insulin Injection Product Portfolio Table 61. United Laboratories Recent Development Table 62. Tonghua Dongbao Company Information Table 63. Tonghua Dongbao Business Overview Table 64. Tonghua Dongbao Long-acting Insulin Injection Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 65. Tonghua Dongbao Long-acting Insulin Injection Product Portfolio Table 66. Tonghua Dongbao Recent Development Table 67. Sanofi Company Information Table 68. Sanofi Business Overview Table 69. Sanofi Long-acting Insulin Injection Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 70. Sanofi Long-acting Insulin Injection Product Portfolio Table 71. Sanofi Recent Development Table 72. Novo Nordisk Company Information Table 73. Novo Nordisk Business Overview Table 74. Novo Nordisk Long-acting Insulin Injection Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 75. Novo Nordisk Long-acting Insulin Injection Product Portfolio Table 76. Novo Nordisk Recent Development Table 77. Eli Lilly & Co Company Information Table 78. Eli Lilly & Co Business Overview Table 79. Eli Lilly & Co Long-acting Insulin Injection Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 80. Eli Lilly & Co Long-acting Insulin Injection Product Portfolio Table 81. Eli Lilly & Co Recent Development Table 82. Gan & Lee Company Information Table 83. Gan & Lee Business Overview Table 84. Gan & Lee Long-acting Insulin Injection Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 85. Gan & Lee Long-acting Insulin Injection Product Portfolio Table 86. Gan & Lee Recent Development Table 87. Wockhardt Company Information Table 88. Wockhardt Business Overview Table 89. Wockhardt Long-acting Insulin Injection Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 90. Wockhardt Long-acting Insulin Injection Product Portfolio Table 91. Wockhardt Recent Development Table 92. Viatris Company Information Table 93. Viatris Business Overview Table 94. Viatris Long-acting Insulin Injection Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 95. Viatris Long-acting Insulin Injection Product Portfolio Table 96. Viatris Recent Development Table 97. Swixx Biopharma Company Information Table 98. Swixx Biopharma Business Overview Table 99. Swixx Biopharma Long-acting Insulin Injection Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 100. Swixx Biopharma Long-acting Insulin Injection Product Portfolio Table 101. Swixx Biopharma Recent Development Table 102. Lupin Laboratories Company Information Table 103. Lupin Laboratories Business Overview Table 104. Lupin Laboratories Long-acting Insulin Injection Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 105. Lupin Laboratories Long-acting Insulin Injection Product Portfolio Table 106. Lupin Laboratories Recent Development Table 107. KALBE PHARMA Company Information Table 108. KALBE PHARMA Business Overview Table 109. KALBE PHARMA Long-acting Insulin Injection Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 110. KALBE PHARMA Long-acting Insulin Injection Product Portfolio Table 111. KALBE PHARMA Recent Development Table 112. INFION PHARMA Company Information Table 113. INFION PHARMA Business Overview Table 114. INFION PHARMA Long-acting Insulin Injection Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 115. INFION PHARMA Long-acting Insulin Injection Product Portfolio Table 116. INFION PHARMA Recent Development Table 117. Cipla Company Information Table 118. Cipla Business Overview Table 119. Cipla Long-acting Insulin Injection Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 120. Cipla Long-acting Insulin Injection Product Portfolio Table 121. Cipla Recent Development Table 122. Biocon Biologics Company Information Table 123. Biocon Biologics Business Overview Table 124. Biocon Biologics Long-acting Insulin Injection Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 125. Biocon Biologics Long-acting Insulin Injection Product Portfolio Table 126. Biocon Biologics Recent Development Table 127. Biocare Company Information Table 128. Biocare Business Overview Table 129. Biocare Long-acting Insulin Injection Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 130. Biocare Long-acting Insulin Injection Product Portfolio Table 131. Biocare Recent Development Table 132. Abbott Laboratories Company Information Table 133. Abbott Laboratories Business Overview Table 134. Abbott Laboratories Long-acting Insulin Injection Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 135. Abbott Laboratories Long-acting Insulin Injection Product Portfolio Table 136. Abbott Laboratories Recent Development Table 137. North America Long-acting Insulin Injection Revenue by Type (2021-2026) & (US$ Million) Table 138. North America Long-acting Insulin Injection Revenue by Type (2027-2032) & (US$ Million) Table 139. North America Long-acting Insulin Injection Sales by Type (2021-2026) & (k units) Table 140. North America Long-acting Insulin Injection Sales by Type (2027-2032) & (k units) Table 141. North America Long-acting Insulin Injection Sales Price by Type (2021-2026) & (USD/unit) Table 142. North America Long-acting Insulin Injection Sales Price by Type (2027-2032) & (USD/unit) Table 143. North America Long-acting Insulin Injection Revenue by Application (2021-2026) & (US$ Million) Table 144. North America Long-acting Insulin Injection Revenue by Application (2027-2032) & (US$ Million) Table 145. North America Long-acting Insulin Injection Sales by Application (2021-2026) & (k units) Table 146. North America Long-acting Insulin Injection Sales by Application (2027-2032) & (k units) Table 147. North America Long-acting Insulin Injection Sales Price by Application (2021-2026) & (USD/unit) Table 148. North America Long-acting Insulin Injection Sales Price by Application (2027-2032) & (USD/unit) Table 149. North America Long-acting Insulin Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 150. North America Long-acting Insulin Injection Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 151. North America Long-acting Insulin Injection Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 152. North America Long-acting Insulin Injection Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 153. North America Long-acting Insulin Injection Sales by Country (2021-2026) & (k units) Table 154. North America Long-acting Insulin Injection Sales by Country (2027-2032) & (k units) Table 155. North America Long-acting Insulin Injection Sales Price by Country (2021-2026) & (USD/unit) Table 156. North America Long-acting Insulin Injection Sales Price by Country (2027-2032) & (USD/unit) Table 157. United States Long-acting Insulin Injection Revenue (2021-2032) & (US$ Million) Table 158. Canada Long-acting Insulin Injection Revenue (2021-2032) & (US$ Million) Table 159. Mexico Long-acting Insulin Injection Revenue (2021-2032) & (US$ Million) Table 160. Europe Long-acting Insulin Injection Revenue by Type (2021-2026) & (US$ Million) Table 161. Europe Long-acting Insulin Injection Revenue by Type (2027-2032) & (US$ Million) Table 162. Europe Long-acting Insulin Injection Sales by Type (2021-2026) & (k units) Table 163. Europe Long-acting Insulin Injection Sales by Type (2027-2032) & (k units) Table 164. Europe Long-acting Insulin Injection Sales Price by Type (2021-2026) & (USD/unit) Table 165. Europe Long-acting Insulin Injection Sales Price by Type (2027-2032) & (USD/unit) Table 166. Europe Long-acting Insulin Injection Revenue by Application (2021-2026) & (US$ Million) Table 167. Europe Long-acting Insulin Injection Revenue by Application (2027-2032) & (US$ Million) Table 168. Europe Long-acting Insulin Injection Sales by Application (2021-2026) & (k units) Table 169. Europe Long-acting Insulin Injection Sales by Application (2027-2032) & (k units) Table 170. Europe Long-acting Insulin Injection Sales Price by Application (2021-2026) & (USD/unit) Table 171. Europe Long-acting Insulin Injection Sales Price by Application (2027-2032) & (USD/unit) Table 172. Europe Long-acting Insulin Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 173. Europe Long-acting Insulin Injection Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 174. Europe Long-acting Insulin Injection Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 175. Europe Long-acting Insulin Injection Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 176. Europe Long-acting Insulin Injection Sales by Country (2021-2026) & (k units) Table 177. Europe Long-acting Insulin Injection Sales by Country (2027-2032) & (k units) Table 178. Europe Long-acting Insulin Injection Sales Price by Country (2021-2026) & (USD/unit) Table 179. Europe Long-acting Insulin Injection Sales Price by Country (2027-2032) & (USD/unit) Table 180. Germany Long-acting Insulin Injection Revenue (2021-2032) & (US$ Million) Table 181. France Long-acting Insulin Injection Revenue (2021-2032) & (US$ Million) Table 182. U.K. Long-acting Insulin Injection Revenue (2021-2032) & (US$ Million) Table 183. Italy Long-acting Insulin Injection Revenue (2021-2032) & (US$ Million) Table 184. Russia Long-acting Insulin Injection Revenue (2021-2032) & (US$ Million) Table 185. Spain Long-acting Insulin Injection Revenue (2021-2032) & (US$ Million) Table 186. Netherlands Long-acting Insulin Injection Revenue (2021-2032) & (US$ Million) Table 187. Switzerland Long-acting Insulin Injection Revenue (2021-2032) & (US$ Million) Table 188. Sweden Long-acting Insulin Injection Revenue (2021-2032) & (US$ Million) Table 189. Poland Long-acting Insulin Injection Revenue (2021-2032) & (US$ Million) Table 190. China Long-acting Insulin Injection Revenue by Type (2021-2026) & (US$ Million) Table 191. China Long-acting Insulin Injection Revenue by Type (2027-2032) & (US$ Million) Table 192. China Long-acting Insulin Injection Sales by Type (2021-2026) & (k units) Table 193. China Long-acting Insulin Injection Sales by Type (2027-2032) & (k units) Table 194. China Long-acting Insulin Injection Sales Price by Type (2021-2026) & (USD/unit) Table 195. China Long-acting Insulin Injection Sales Price by Type (2027-2032) & (USD/unit) Table 196. China Long-acting Insulin Injection Revenue by Application (2021-2026) & (US$ Million) Table 197. China Long-acting Insulin Injection Revenue by Application (2027-2032) & (US$ Million) Table 198. China Long-acting Insulin Injection Sales by Application (2021-2026) & (k units) Table 199. China Long-acting Insulin Injection Sales by Application (2027-2032) & (k units) Table 200. China Long-acting Insulin Injection Sales Price by Application (2021-2026) & (USD/unit) Table 201. China Long-acting Insulin Injection Sales Price by Application (2027-2032) & (USD/unit) Table 202. Asia Long-acting Insulin Injection Revenue by Type (2021-2026) & (US$ Million) Table 203. Asia Long-acting Insulin Injection Revenue by Type (2027-2032) & (US$ Million) Table 204. Asia Long-acting Insulin Injection Sales by Type (2021-2026) & (k units) Table 205. Asia Long-acting Insulin Injection Sales by Type (2027-2032) & (k units) Table 206. Asia Long-acting Insulin Injection Sales Price by Type (2021-2026) & (USD/unit) Table 207. Asia Long-acting Insulin Injection Sales Price by Type (2027-2032) & (USD/unit) Table 208. Asia Long-acting Insulin Injection Revenue by Application (2021-2026) & (US$ Million) Table 209. Asia Long-acting Insulin Injection Revenue by Application (2027-2032) & (US$ Million) Table 210. Asia Long-acting Insulin Injection Sales by Application (2021-2026) & (k units) Table 211. Asia Long-acting Insulin Injection Sales by Application (2027-2032) & (k units) Table 212. Asia Long-acting Insulin Injection Sales Price by Application (2021-2026) & (USD/unit) Table 213. Asia Long-acting Insulin Injection Sales Price by Application (2027-2032) & (USD/unit) Table 214. Asia Long-acting Insulin Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 215. Asia Long-acting Insulin Injection Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 216. Asia Long-acting Insulin Injection Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 217. Asia Long-acting Insulin Injection Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 218. Asia Long-acting Insulin Injection Sales by Country (2021-2026) & (k units) Table 219. Asia Long-acting Insulin Injection Sales by Country (2027-2032) & (k units) Table 220. Asia Long-acting Insulin Injection Sales Price by Country (2021-2026) & (USD/unit) Table 221. Asia Long-acting Insulin Injection Sales Price by Country (2027-2032) & (USD/unit) Table 222. Japan Long-acting Insulin Injection Revenue (2021-2032) & (US$ Million) Table 223. South Korea Long-acting Insulin Injection Revenue (2021-2032) & (US$ Million) Table 224. India Long-acting Insulin Injection Revenue (2021-2032) & (US$ Million) Table 225. Australia Long-acting Insulin Injection Revenue (2021-2032) & (US$ Million) Table 226. Taiwan Long-acting Insulin Injection Revenue (2021-2032) & (US$ Million) Table 227. Southeast Asia Long-acting Insulin Injection Revenue (2021-2032) & (US$ Million) Table 228. SAMEA Long-acting Insulin Injection Revenue by Type (2021-2026) & (US$ Million) Table 229. SAMEA Long-acting Insulin Injection Revenue by Type (2027-2032) & (US$ Million) Table 230. SAMEA Long-acting Insulin Injection Sales by Type (2021-2026) & (k units) Table 231. SAMEA Long-acting Insulin Injection Sales by Type (2027-2032) & (k units) Table 232. SAMEA Long-acting Insulin Injection Sales Price by Type (2021-2026) & (USD/unit) Table 233. SAMEA Long-acting Insulin Injection Sales Price by Type (2027-2032) & (USD/unit) Table 234. SAMEA Long-acting Insulin Injection Revenue by Application (2021-2026) & (US$ Million) Table 235. SAMEA Long-acting Insulin Injection Revenue by Application (2027-2032) & (US$ Million) Table 236. SAMEA Long-acting Insulin Injection Sales by Application (2021-2026) & (k units) Table 237. SAMEA Long-acting Insulin Injection Sales by Application (2027-2032) & (k units) Table 238. SAMEA Long-acting Insulin Injection Sales Price by Application (2021-2026) & (USD/unit) Table 239. SAMEA Long-acting Insulin Injection Sales Price by Application (2027-2032) & (USD/unit) Table 240. SAMEA Long-acting Insulin Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 241. SAMEA Long-acting Insulin Injection Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 242. SAMEA Long-acting Insulin Injection Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 243. SAMEA Long-acting Insulin Injection Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 244. SAMEA Long-acting Insulin Injection Sales by Country (2021-2026) & (k units) Table 245. SAMEA Long-acting Insulin Injection Sales by Country (2027-2032) & (k units) Table 246. SAMEA Long-acting Insulin Injection Sales Price by Country (2021-2026) & (USD/unit) Table 247. SAMEA Long-acting Insulin Injection Sales Price by Country (2027-2032) & (USD/unit) Table 248. Brazil Long-acting Insulin Injection Revenue (2021-2032) & (US$ Million) Table 249. Argentina Long-acting Insulin Injection Revenue (2021-2032) & (US$ Million) Table 250. Chile Long-acting Insulin Injection Revenue (2021-2032) & (US$ Million) Table 251. Colombia Long-acting Insulin Injection Revenue (2021-2032) & (US$ Million) Table 252. Peru Long-acting Insulin Injection Revenue (2021-2032) & (US$ Million) Table 253. Saudi Arabia Long-acting Insulin Injection Revenue (2021-2032) & (US$ Million) Table 254. Israel Long-acting Insulin Injection Revenue (2021-2032) & (US$ Million) Table 255. UAE Long-acting Insulin Injection Revenue (2021-2032) & (US$ Million) Table 256. Turkey Long-acting Insulin Injection Revenue (2021-2032) & (US$ Million) Table 257. Iran Long-acting Insulin Injection Revenue (2021-2032) & (US$ Million) Table 258. Egypt Long-acting Insulin Injection Revenue (2021-2032) & (US$ Million) Table 259. Key Raw Materials Table 260. Raw Materials Key Suppliers Table 261. Long-acting Insulin Injection Distributors List Table 262. Long-acting Insulin Injection Customers List Table 263. Research Programs/Design for This Report Table 264. Authors List of This Report Table 265. Secondary Sources Table 266. Primary Sources List of Figures Figure 1. Long-acting Insulin Injection Image Figure 2. Global Long-acting Insulin Injection Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Long-acting Insulin Injection Market Size Share 2021 VS 2025 VS 2032 Figure 4. Insulin Glargine Image Figure 5. Insulin Detemir Image Figure 6. Insulin Degludec Image Figure 7. Global Long-acting Insulin Injection Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Long-acting Insulin Injection Market Size Share 2021 VS 2025 VS 2032 Figure 9. Type 1 Diabetes Image Figure 10. Type 2 Diabetes Image Figure 11. Global Long-acting Insulin Injection Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Long-acting Insulin Injection Revenue (2021-2032) & (US$ Million) Figure 13. Global Long-acting Insulin Injection Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 14. Global Long-acting Insulin Injection Revenue Market Share by Region: 2025 Versus 2032 Figure 15. Global Long-acting Insulin Injection Revenue Market Share by Region (2021-2032) Figure 16. Global Long-acting Insulin Injection Sales (2021-2032) & (k units) Figure 17. Global Long-acting Insulin Injection Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 18. Global Long-acting Insulin Injection Sales Market Share by Region (2021-2032) Figure 19. US & Canada & Mexico Long-acting Insulin Injection Sales YoY (2021-2032) & (k units) Figure 20. Europe Long-acting Insulin Injection Sales YoY (2021-2032) & (k units) Figure 21. China Long-acting Insulin Injection Sales YoY (2021-2032) & (k units) Figure 22. Asia (Excluding China) Long-acting Insulin Injection Sales YoY (2021-2032) & (k units) Figure 23. South America, Middle East and Africa Long-acting Insulin Injection Sales YoY (2021-2032) & (k units) Figure 24. Global Long-acting Insulin Injection Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 25. Global Long-acting Insulin Injection Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 26. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Global Long-acting Insulin Injection Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Long-acting Insulin Injection Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 29. Global Long-acting Insulin Injection Revenue Market Share by Type (2021-2032) Figure 30. Global Long-acting Insulin Injection Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 31. Global Long-acting Insulin Injection Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Long-acting Insulin Injection Sales Market Share by Type (2021-2032) Figure 33. Global Long-acting Insulin Injection Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 34. Global Long-acting Insulin Injection Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 35. Global Long-acting Insulin Injection Revenue Market Share by Application (2021-2032) Figure 36. Global Long-acting Insulin Injection Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 37. Global Long-acting Insulin Injection Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Long-acting Insulin Injection Sales Market Share by Application (2021-2032) Figure 39. North America Long-acting Insulin Injection Revenue Share by Type (2021-2032) Figure 40. North America Long-acting Insulin Injection Sales Share by Type (2021-2032) Figure 41. North America Long-acting Insulin Injection Revenue Share by Application (2021-2032) Figure 42. North America Long-acting Insulin Injection Sales Share by Application (2021-2032) Figure 43. North America Long-acting Insulin Injection Revenue Share by Country (2021-2032) Figure 44. North America Long-acting Insulin Injection Sales Share by Country (2021-2032) Figure 45. Europe Long-acting Insulin Injection Revenue Share by Type (2021-2032) Figure 46. Europe Long-acting Insulin Injection Sales Share by Type (2021-2032) Figure 47. Europe Long-acting Insulin Injection Revenue Share by Application (2021-2032) Figure 48. Europe Long-acting Insulin Injection Sales Share by Application (2021-2032) Figure 49. Europe Long-acting Insulin Injection Revenue Share by Country (2021-2032) Figure 50. Europe Long-acting Insulin Injection Sales Share by Country (2021-2032) Figure 51. China Long-acting Insulin Injection Revenue Share by Type (2021-2032) Figure 52. China Long-acting Insulin Injection Sales Share by Type (2021-2032) Figure 53. China Long-acting Insulin Injection Revenue Share by Application (2021-2032) Figure 54. China Long-acting Insulin Injection Sales Share by Application (2021-2032) Figure 55. Asia Long-acting Insulin Injection Revenue Share by Type (2021-2032) Figure 56. Asia Long-acting Insulin Injection Sales Share by Type (2021-2032) Figure 57. Asia Long-acting Insulin Injection Revenue Share by Application (2021-2032) Figure 58. Asia Long-acting Insulin Injection Sales Share by Application (2021-2032) Figure 59. Asia Long-acting Insulin Injection Revenue Share by Country (2021-2032) Figure 60. Asia Long-acting Insulin Injection Sales Share by Country (2021-2032) Figure 61. SAMEA Long-acting Insulin Injection Revenue Share by Type (2021-2032) Figure 62. SAMEA Long-acting Insulin Injection Sales Share by Type (2021-2032) Figure 63. SAMEA Long-acting Insulin Injection Revenue Share by Application (2021-2032) Figure 64. SAMEA Long-acting Insulin Injection Sales Share by Application (2021-2032) Figure 65. SAMEA Long-acting Insulin Injection Revenue Share by Country (2021-2032) Figure 66. SAMEA Long-acting Insulin Injection Sales Share by Country (2021-2032) Figure 67. Long-acting Insulin Injection Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Long-acting Insulin Injection Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Insulin Glargine
  • Insulin Detemir
  • Insulin Degludec
Applications
  • Type 1 Diabetes
  • Type 2 Diabetes
Companies covered
  • United Laboratories
  • Tonghua Dongbao
  • Sanofi
  • Novo Nordisk
  • Eli Lilly & Co
  • Gan & Lee
  • Wockhardt
  • Viatris
  • Swixx Biopharma
  • Lupin Laboratories
  • KALBE PHARMA
  • INFION PHARMA
  • Cipla
  • Biocon Biologics
  • Biocare
  • Abbott Laboratories

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Long-acting Insulin Injection Market by Type
  3. 1.2.1 Global Long-acting Insulin Injection Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Insulin Glargine
  5. 1.2.3 Insulin Detemir
  6. 1.2.4 Insulin Degludec
  7. 1.3 Long-acting Insulin Injection Market by Application
  8. 1.3.1 Global Long-acting Insulin Injection Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Type 1 Diabetes
  10. 1.3.3 Type 2 Diabetes
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Long-acting Insulin Injection Market Dynamics
  1. 2.1 Long-acting Insulin Injection Industry Trends
  2. 2.2 Long-acting Insulin Injection Industry Drivers
  3. 2.3 Long-acting Insulin Injection Industry Opportunities and Challenges
  4. 2.4 Long-acting Insulin Injection Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Long-acting Insulin Injection Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Long-acting Insulin Injection Revenue by Region
  3. 3.2.1 Global Long-acting Insulin Injection Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Long-acting Insulin Injection Revenue by Region (2021-2026)
  5. 3.2.3 Global Long-acting Insulin Injection Revenue by Region (2027-2032)
  6. 3.2.4 Global Long-acting Insulin Injection Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Long-acting Insulin Injection Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Long-acting Insulin Injection Sales by Region
  9. 3.4.1 Global Long-acting Insulin Injection Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Long-acting Insulin Injection Sales by Region (2021-2026)
  11. 3.4.3 Global Long-acting Insulin Injection Sales by Region (2027-2032)
  12. 3.4.4 Global Long-acting Insulin Injection Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Long-acting Insulin Injection Revenue by Manufacturers
  2. 4.1.1 Global Long-acting Insulin Injection Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Long-acting Insulin Injection Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Long-acting Insulin Injection Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Long-acting Insulin Injection Sales by Manufacturers
  6. 4.2.1 Global Long-acting Insulin Injection Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Long-acting Insulin Injection Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Long-acting Insulin Injection Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Long-acting Insulin Injection Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Long-acting Insulin Injection Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Long-acting Insulin Injection Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Long-acting Insulin Injection Manufacturers, Product Type & Application
  13. 4.7 Global Long-acting Insulin Injection Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Long-acting Insulin Injection Market CR5 and HHI
  16. 4.8.2 2025 Long-acting Insulin Injection Tier 1, Tier 2, and Tier 3
5 Long-acting Insulin Injection Market by Type
  1. 5.1 Global Long-acting Insulin Injection Revenue by Type
  2. 5.1.1 Global Long-acting Insulin Injection Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Long-acting Insulin Injection Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Long-acting Insulin Injection Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Long-acting Insulin Injection Sales by Type
  6. 5.2.1 Global Long-acting Insulin Injection Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Long-acting Insulin Injection Sales by Type (2021-2032) & (k units)
  8. 5.2.3 Global Long-acting Insulin Injection Sales Market Share by Type (2021-2032)
  9. 5.3 Global Long-acting Insulin Injection Price by Type
6 Long-acting Insulin Injection Market by Application
  1. 6.1 Global Long-acting Insulin Injection Revenue by Application
  2. 6.1.1 Global Long-acting Insulin Injection Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Long-acting Insulin Injection Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Long-acting Insulin Injection Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Long-acting Insulin Injection Sales by Application
  6. 6.2.1 Global Long-acting Insulin Injection Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Long-acting Insulin Injection Sales by Application (2021-2032) & (k units)
  8. 6.2.3 Global Long-acting Insulin Injection Sales Market Share by Application (2021-2032)
  9. 6.3 Global Long-acting Insulin Injection Price by Application
7 Company Profiles
  1. 7.1 United Laboratories
  2. 7.1.1 United Laboratories Company Information
  3. 7.1.2 United Laboratories Business Overview
  4. 7.1.3 United Laboratories Long-acting Insulin Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 United Laboratories Long-acting Insulin Injection Product Portfolio
  6. 7.1.5 United Laboratories Recent Developments
  7. 7.2 Tonghua Dongbao
  8. 7.2.1 Tonghua Dongbao Company Information
  9. 7.2.2 Tonghua Dongbao Business Overview
  10. 7.2.3 Tonghua Dongbao Long-acting Insulin Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Tonghua Dongbao Long-acting Insulin Injection Product Portfolio
  12. 7.2.5 Tonghua Dongbao Recent Developments
  13. 7.3 Sanofi
  14. 7.3.1 Sanofi Company Information
  15. 7.3.2 Sanofi Business Overview
  16. 7.3.3 Sanofi Long-acting Insulin Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Sanofi Long-acting Insulin Injection Product Portfolio
  18. 7.3.5 Sanofi Recent Developments
  19. 7.4 Novo Nordisk
  20. 7.4.1 Novo Nordisk Company Information
  21. 7.4.2 Novo Nordisk Business Overview
  22. 7.4.3 Novo Nordisk Long-acting Insulin Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Novo Nordisk Long-acting Insulin Injection Product Portfolio
  24. 7.4.5 Novo Nordisk Recent Developments
  25. 7.5 Eli Lilly & Co
  26. 7.5.1 Eli Lilly & Co Company Information
  27. 7.5.2 Eli Lilly & Co Business Overview
  28. 7.5.3 Eli Lilly & Co Long-acting Insulin Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Eli Lilly & Co Long-acting Insulin Injection Product Portfolio
  30. 7.5.5 Eli Lilly & Co Recent Developments
  31. 7.6 Gan & Lee
  32. 7.6.1 Gan & Lee Company Information
  33. 7.6.2 Gan & Lee Business Overview
  34. 7.6.3 Gan & Lee Long-acting Insulin Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Gan & Lee Long-acting Insulin Injection Product Portfolio
  36. 7.6.5 Gan & Lee Recent Developments
  37. 7.7 Wockhardt
  38. 7.7.1 Wockhardt Company Information
  39. 7.7.2 Wockhardt Business Overview
  40. 7.7.3 Wockhardt Long-acting Insulin Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Wockhardt Long-acting Insulin Injection Product Portfolio
  42. 7.7.5 Wockhardt Recent Developments
  43. 7.8 Viatris
  44. 7.8.1 Viatris Company Information
  45. 7.8.2 Viatris Business Overview
  46. 7.8.3 Viatris Long-acting Insulin Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Viatris Long-acting Insulin Injection Product Portfolio
  48. 7.8.5 Viatris Recent Developments
  49. 7.9 Swixx Biopharma
  50. 7.9.1 Swixx Biopharma Company Information
  51. 7.9.2 Swixx Biopharma Business Overview
  52. 7.9.3 Swixx Biopharma Long-acting Insulin Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Swixx Biopharma Long-acting Insulin Injection Product Portfolio
  54. 7.9.5 Swixx Biopharma Recent Developments
  55. 7.10 Lupin Laboratories
  56. 7.10.1 Lupin Laboratories Company Information
  57. 7.10.2 Lupin Laboratories Business Overview
  58. 7.10.3 Lupin Laboratories Long-acting Insulin Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Lupin Laboratories Long-acting Insulin Injection Product Portfolio
  60. 7.10.5 Lupin Laboratories Recent Developments
  61. 7.11 KALBE PHARMA
  62. 7.11.1 KALBE PHARMA Company Information
  63. 7.11.2 KALBE PHARMA Business Overview
  64. 7.11.3 KALBE PHARMA Long-acting Insulin Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 KALBE PHARMA Long-acting Insulin Injection Product Portfolio
  66. 7.11.5 KALBE PHARMA Recent Developments
  67. 7.12 INFION PHARMA
  68. 7.12.1 INFION PHARMA Company Information
  69. 7.12.2 INFION PHARMA Business Overview
  70. 7.12.3 INFION PHARMA Long-acting Insulin Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 INFION PHARMA Long-acting Insulin Injection Product Portfolio
  72. 7.12.5 INFION PHARMA Recent Developments
  73. 7.13 Cipla
  74. 7.13.1 Cipla Company Information
  75. 7.13.2 Cipla Business Overview
  76. 7.13.3 Cipla Long-acting Insulin Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 Cipla Long-acting Insulin Injection Product Portfolio
  78. 7.13.5 Cipla Recent Developments
  79. 7.14 Biocon Biologics
  80. 7.14.1 Biocon Biologics Company Information
  81. 7.14.2 Biocon Biologics Business Overview
  82. 7.14.3 Biocon Biologics Long-acting Insulin Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 7.14.4 Biocon Biologics Long-acting Insulin Injection Product Portfolio
  84. 7.14.5 Biocon Biologics Recent Developments
  85. 7.15 Biocare
  86. 7.15.1 Biocare Company Information
  87. 7.15.2 Biocare Business Overview
  88. 7.15.3 Biocare Long-acting Insulin Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  89. 7.15.4 Biocare Long-acting Insulin Injection Product Portfolio
  90. 7.15.5 Biocare Recent Developments
  91. 7.16 Abbott Laboratories
  92. 7.16.1 Abbott Laboratories Company Information
  93. 7.16.2 Abbott Laboratories Business Overview
  94. 7.16.3 Abbott Laboratories Long-acting Insulin Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  95. 7.16.4 Abbott Laboratories Long-acting Insulin Injection Product Portfolio
  96. 7.16.5 Abbott Laboratories Recent Developments
8 North America
  1. 8.1 North America Long-acting Insulin Injection Market Size by Type
  2. 8.1.1 North America Long-acting Insulin Injection Revenue by Type (2021-2032)
  3. 8.1.2 North America Long-acting Insulin Injection Sales by Type (2021-2032)
  4. 8.1.3 North America Long-acting Insulin Injection Price by Type (2021-2032)
  5. 8.2 North America Long-acting Insulin Injection Market Size by Application
  6. 8.2.1 North America Long-acting Insulin Injection Revenue by Application (2021-2032)
  7. 8.2.2 North America Long-acting Insulin Injection Sales by Application (2021-2032)
  8. 8.2.3 North America Long-acting Insulin Injection Price by Application (2021-2032)
  9. 8.3 North America Long-acting Insulin Injection Market Size by Country
  10. 8.3.1 North America Long-acting Insulin Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Long-acting Insulin Injection Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Long-acting Insulin Injection Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Long-acting Insulin Injection Market Size by Type
  2. 9.1.1 Europe Long-acting Insulin Injection Revenue by Type (2021-2032)
  3. 9.1.2 Europe Long-acting Insulin Injection Sales by Type (2021-2032)
  4. 9.1.3 Europe Long-acting Insulin Injection Price by Type (2021-2032)
  5. 9.2 Europe Long-acting Insulin Injection Market Size by Application
  6. 9.2.1 Europe Long-acting Insulin Injection Revenue by Application (2021-2032)
  7. 9.2.2 Europe Long-acting Insulin Injection Sales by Application (2021-2032)
  8. 9.2.3 Europe Long-acting Insulin Injection Price by Application (2021-2032)
  9. 9.3 Europe Long-acting Insulin Injection Market Size by Country
  10. 9.3.1 Europe Long-acting Insulin Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Long-acting Insulin Injection Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Long-acting Insulin Injection Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Long-acting Insulin Injection Market Size by Type
  2. 10.1.1 China Long-acting Insulin Injection Revenue by Type (2021-2032)
  3. 10.1.2 China Long-acting Insulin Injection Sales by Type (2021-2032)
  4. 10.1.3 China Long-acting Insulin Injection Price by Type (2021-2032)
  5. 10.2 China Long-acting Insulin Injection Market Size by Application
  6. 10.2.1 China Long-acting Insulin Injection Revenue by Application (2021-2032)
  7. 10.2.2 China Long-acting Insulin Injection Sales by Application (2021-2032)
  8. 10.2.3 China Long-acting Insulin Injection Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Long-acting Insulin Injection Market Size by Type
  2. 11.1.1 Asia Long-acting Insulin Injection Revenue by Type (2021-2032)
  3. 11.1.2 Asia Long-acting Insulin Injection Sales by Type (2021-2032)
  4. 11.1.3 Asia Long-acting Insulin Injection Price by Type (2021-2032)
  5. 11.2 Asia Long-acting Insulin Injection Market Size by Application
  6. 11.2.1 Asia Long-acting Insulin Injection Revenue by Application (2021-2032)
  7. 11.2.2 Asia Long-acting Insulin Injection Sales by Application (2021-2032)
  8. 11.2.3 Asia Long-acting Insulin Injection Price by Application (2021-2032)
  9. 11.3 Asia Long-acting Insulin Injection Market Size by Country
  10. 11.3.1 Asia Long-acting Insulin Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Long-acting Insulin Injection Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Long-acting Insulin Injection Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Long-acting Insulin Injection Market Size by Type
  2. 12.1.1 SAMEA Long-acting Insulin Injection Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Long-acting Insulin Injection Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Long-acting Insulin Injection Price by Type (2021-2032)
  5. 12.2 SAMEA Long-acting Insulin Injection Market Size by Application
  6. 12.2.1 SAMEA Long-acting Insulin Injection Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Long-acting Insulin Injection Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Long-acting Insulin Injection Price by Application (2021-2032)
  9. 12.3 SAMEA Long-acting Insulin Injection Market Size by Country
  10. 12.3.1 SAMEA Long-acting Insulin Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Long-acting Insulin Injection Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Long-acting Insulin Injection Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Long-acting Insulin Injection Value Chain Analysis
  2. 13.1.1 Long-acting Insulin Injection Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Long-acting Insulin Injection Production Mode & Process
  6. 13.2 Long-acting Insulin Injection Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Long-acting Insulin Injection Distributors
  9. 13.2.3 Long-acting Insulin Injection Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst